<DOC>
	<DOCNO>NCT01954264</DOCNO>
	<brief_summary>This study design characterise P. falciparum transmission intensity subject age ≥6 month &lt; 10 year measurement P. falciparum parasite prevalence , estimate use malaria control intervention centre select EPI-MAL-002 EPI-MAL-003 study sub-Saharan Western Africa .</brief_summary>
	<brief_title>Epidemiology Study Malaria Transmission Intensity Sub-Saharan Africa</brief_title>
	<detailed_description>Two subsequent study ( EPI-MAL-002 EPI-MAL-003 ) plan monitor vaccine safety prior implementation RTS , S/AS01 candidate malaria vaccine . EPI-MAL-002 take place RTS , S authorise EPI-MAL-003 start RTS , S register authorised country . A cross-sectional survey peak transmission provide by-site point estimate Parasite prevalence ( PP ) malaria control measure coverage area participate EPI-MAL-002/-003 . EPI-MAL-006 conduct advance EPI-MAL-002/-003 order ass PP malaria control measure inform enrollment study . The age group enrollment ( ≥6 month - &lt; 10 year ) permit analysis PP accord World Health Organization ( WHO ) definition ( 2-9 year ) Joint Technical Expert Group ( JTEG ) suggest age ( &lt; 5 year ) .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<criteria>Subjects ' parent ( ) /Legally Acceptable Representative ( ) [ LAR ( ) ] , opinion investigator , comply requirement protocol . A male female equal 6 month age less 10 year age time survey . Signed informed consent thumbprinted witness informed consent obtain parent ( ) /LAR ( ) child . Child care . Current active participation trial involve administration investigational malaria vaccine malaria drug .</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>9 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Saharan Western Africa</keyword>
	<keyword>Epidemiology</keyword>
	<keyword>Post-Approval Programme study</keyword>
	<keyword>Malaria</keyword>
	<keyword>Burden Disease Study</keyword>
</DOC>